Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Compact Design, Big Impact: Tridek-One Therapeutics Leverages MyGlo® to Accelerate Discovery of Immunomodulating Treatments
Tridek-One Therapeutics, a biotech firm based in Paris, adopted the MyGlo® Reagent Reader to enhance their workflow for developing CD31 checkpoint therapies. This compa...
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page